Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan

Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan

Abstract Background The investigational medicinal product GKT137831 is a selective inhibitor of NOX 1 and 4 isoforms of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family of enzymes, which has the potential to ameliorate diabetic kidney disease. An investigator-initiated, double-...

Full description

Bibliographic Details
Main Authors: Alysha M. De Livera, Anne Reutens, Mark Cooper, Merlin Thomas, Karin Jandeleit-Dahm, Jonathan E. Shaw, Agus Salim
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
Statistical analysis plan
Randomised controlled trial
GKT137831
Albuminuria
Type 1 diabetes
Online Access:http://link.springer.com/article/10.1186/s13063-020-04404-0

Similar Items

Similar Items